Literature DB >> 28061328

Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis.

.   

Abstract

This article updates the Calcium Hypothesis of Alzheimer's disease and brain aging on the basis of emerging evidence since 1994 (The present article, with the subtitle "New evidence for a central role of Ca2+ in neurodegeneration," includes three appendices that provide context and further explanations for the rationale for the revisions in the updated hypothesis-the three appendices are as follows: Appendix I "Emerging concepts on potential pathogenic roles of [Ca2+]," Appendix II "Future studies to validate the central role of dysregulated [Ca2+] in neurodegeneration," and Appendix III "Epilogue: towards a comprehensive hypothesis.") (Marx J. Fresh evidence points to an old suspect: calcium. Science 2007; 318:384-385). The aim is not only to re-evaluate the original key claims of the hypothesis with a critical eye but also to identify gaps in knowledge required to validate relevant claims and delineate additional studies and/or data that are needed. Some of the key challenges for this effort included examination of questions regarding (1) the temporal and spatial relationships of molecular mechanisms that regulate neuronal calcium ion (Ca2+), (2) the role of changes in concentration of calcium ion [Ca2+] in various subcellular compartments of neurons, (3) how alterations in Ca2+ signaling affect the performance of neurons under various conditions, ranging from optimal functioning in a healthy state to conditions of decline and deterioration in performance during aging and in disease, and (4) new ideas about the contributions of aging, genetic, and environmental factors to the causal relationships between dysregulation of [Ca2+] and the functioning of neurons (see Appendices I and II). The updated Calcium Hypothesis also includes revised postulates that are intended to promote further crucial experiments to confirm or reject the various predictions of the hypothesis (see Appendix III).
Copyright © 2016 the Alzheimer's Association. All rights reserved.

Entities:  

Keywords:  Aging; Aging mechanism; Alzheimer's disease; Amyloid; Brain; Calcium; Dementia; Development; Hypothesis; Model; Neurodegeneration; Neuron; Performance; Tau

Mesh:

Substances:

Year:  2017        PMID: 28061328     DOI: 10.1016/j.jalz.2016.12.006

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  100 in total

1.  Novel methods for integration and visualization of genomics and genetics data in Alzheimer's disease.

Authors:  Nathan A Bihlmeyer; Emily Merrill; Yann Lambert; Gyan P Srivastava; Timothy W Clark; Bradley T Hyman; Sudeshna Das
Journal:  Alzheimers Dement       Date:  2019-03-29       Impact factor: 21.566

2.  Dairy, soy, and calcium consumption and risk of cognitive impairment: the Singapore Chinese Health Study.

Authors:  Mohammad Talaei; Lei Feng; Jian-Min Yuan; An Pan; Woon-Puay Koh
Journal:  Eur J Nutr       Date:  2019-06-03       Impact factor: 5.614

Review 3.  Preventing dementia by preventing stroke: The Berlin Manifesto.

Authors:  Vladimir Hachinski; Karl Einhäupl; Detlev Ganten; Suvarna Alladi; Carol Brayne; Blossom C M Stephan; Melanie D Sweeney; Berislav Zlokovic; Yasser Iturria-Medina; Costantino Iadecola; Nozomi Nishimura; Chris B Schaffer; Shawn N Whitehead; Sandra E Black; Leif Østergaard; Joanna Wardlaw; Steven Greenberg; Leif Friberg; Bo Norrving; Brian Rowe; Yves Joanette; Werner Hacke; Lewis Kuller; Martin Dichgans; Matthias Endres; Zaven S Khachaturian
Journal:  Alzheimers Dement       Date:  2019-07       Impact factor: 21.566

4.  Amyloid-Beta Modulates Low-Threshold Activated Voltage-Gated L-Type Calcium Channels of Arcuate Neuropeptide Y Neurons Leading to Calcium Dysregulation and Hypothalamic Dysfunction.

Authors:  Makoto Ishii; Abigail J Hiller; Laurie Pham; Matthew J McGuire; Costantino Iadecola; Gang Wang
Journal:  J Neurosci       Date:  2019-09-19       Impact factor: 6.167

5.  The protective role of miR-132 targeting HMGA2 through the PI3K/AKT pathway in mice with Alzheimer's disease.

Authors:  Xichang Liu; Haitao Wang; Jiawei Bei; Jun Zhao; Ge Jiang; Xiuhong Liu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 6.  Calcium signaling and molecular mechanisms underlying neurodegenerative diseases.

Authors:  Ekaterina Pchitskaya; Elena Popugaeva; Ilya Bezprozvanny
Journal:  Cell Calcium       Date:  2017-06-30       Impact factor: 6.817

7.  Granisetron Alleviates Alzheimer's Disease Pathology in TgSwDI Mice Through Calmodulin-Dependent Protein Kinase II/cAMP-Response Element Binding Protein Pathway.

Authors:  Sweilem B Al Rihani; Renny S Lan; Amal Kaddoumi
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

8.  Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease.

Authors:  Elena Popugaeva; Daria Chernyuk; Ilya Bezprozvanny
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

9.  Ca:Mg Ratio, APOE Cytosine Modifications, and Cognitive Function: Results from a Randomized Trial.

Authors:  Xiangzhu Zhu; Amy R Borenstein; Yinan Zheng; Wei Zhang; Douglas L Seidner; Reid Ness; Harvey J Murff; Bingshan Li; Martha J Shrubsole; Chang Yu; Lifang Hou; Qi Dai
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 10.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.